MERCK Kommanditgesellschaft auf Aktien (MRK.DE)
EUR 134.2
(-0.26%)
EUR 134.2
(-0.26%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 11.66 Billion EUR | -14.86% |
| 2022 | 13.7 Billion EUR | 11.1% |
| 2021 | 12.33 Billion EUR | 15.3% |
| 2020 | 10.69 Billion EUR | 5.45% |
| 2019 | 10.14 Billion EUR | 7.32% |
| 2018 | 9.45 Billion EUR | -5.53% |
| 2017 | 10 Billion EUR | 1.87% |
| 2016 | 9.82 Billion EUR | 12.03% |
| 2015 | 8.76 Billion EUR | 17.9% |
| 2014 | 7.43 Billion EUR | -1.31% |
| 2013 | 7.53 Billion EUR | 1.35% |
| 2012 | 7.43 Billion EUR | -0.7% |
| 2011 | 7.48 Billion EUR | 8.44% |
| 2010 | 6.9 Billion EUR | 20.77% |
| 2009 | 5.71 Billion EUR | 1.16% |
| 2008 | 5.65 Billion EUR | 7.1% |
| 2007 | 5.27 Billion EUR | 37.25% |
| 2006 | 3.84 Billion EUR | 9.83% |
| 2005 | 3.5 Billion EUR | 13.29% |
| 2004 | 3.09 Billion EUR | -14.88% |
| 2003 | 3.63 Billion EUR | 0.7% |
| 2002 | 3.6 Billion EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 3.23 Billion EUR | 7.44% |
| 2024 Q1 | 3 Billion EUR | 3.83% |
| 2023 Q1 | 3.32 Billion EUR | -1.66% |
| 2023 Q2 | 3.16 Billion EUR | -4.73% |
| 2023 FY | 11.66 Billion EUR | -14.86% |
| 2023 Q4 | 2.89 Billion EUR | -3.75% |
| 2023 Q3 | 3.01 Billion EUR | -4.81% |
| 2022 FY | 13.7 Billion EUR | 11.1% |
| 2022 Q1 | 3.21 Billion EUR | -1.32% |
| 2022 Q2 | 3.45 Billion EUR | 7.72% |
| 2022 Q4 | 3.37 Billion EUR | -7.73% |
| 2022 Q3 | 3.65 Billion EUR | 5.78% |
| 2021 Q3 | 3.11 Billion EUR | 1.86% |
| 2021 Q4 | 3.25 Billion EUR | 4.5% |
| 2021 FY | 12.33 Billion EUR | 15.3% |
| 2021 Q1 | 2.91 Billion EUR | 3.82% |
| 2021 Q2 | 3.05 Billion EUR | 5.05% |
| 2020 FY | 10.69 Billion EUR | 5.45% |
| 2020 Q1 | 2.71 Billion EUR | 0.93% |
| 2020 Q2 | 2.5 Billion EUR | -7.62% |
| 2020 Q3 | 2.67 Billion EUR | 6.46% |
| 2020 Q4 | 2.8 Billion EUR | 4.94% |
| 2019 Q4 | 2.69 Billion EUR | 4.46% |
| 2019 Q1 | 2.36 Billion EUR | -2.8% |
| 2019 Q2 | 2.51 Billion EUR | 6.56% |
| 2019 Q3 | 2.57 Billion EUR | 2.34% |
| 2019 FY | 10.14 Billion EUR | 7.32% |
| 2018 Q4 | 2.43 Billion EUR | 1.04% |
| 2018 Q2 | 2.39 Billion EUR | 0.93% |
| 2018 Q1 | 2.37 Billion EUR | -3.34% |
| 2018 FY | 9.45 Billion EUR | -5.53% |
| 2018 Q3 | 2.4 Billion EUR | 0.5% |
| 2017 Q3 | 2.42 Billion EUR | -5.16% |
| 2017 Q2 | 2.56 Billion EUR | -0.19% |
| 2017 Q1 | 2.56 Billion EUR | 2.52% |
| 2017 FY | 10 Billion EUR | 1.87% |
| 2017 Q4 | 2.45 Billion EUR | 1.03% |
| 2016 Q1 | 2.35 Billion EUR | 1.88% |
| 2016 Q4 | 2.5 Billion EUR | 1.17% |
| 2016 Q3 | 2.47 Billion EUR | -0.68% |
| 2016 Q2 | 2.49 Billion EUR | 5.6% |
| 2016 FY | 9.82 Billion EUR | 12.03% |
| 2015 Q2 | 2.2 Billion EUR | 6.6% |
| 2015 FY | 8.76 Billion EUR | 17.9% |
| 2015 Q4 | 2.31 Billion EUR | 6.08% |
| 2015 Q3 | 2.18 Billion EUR | -1.03% |
| 2015 Q1 | 2.06 Billion EUR | 7.67% |
| 2014 Q4 | 1.92 Billion EUR | 3.61% |
| 2014 FY | 7.43 Billion EUR | -1.31% |
| 2014 Q1 | 1.79 Billion EUR | -2.33% |
| 2014 Q2 | 1.89 Billion EUR | 5.77% |
| 2014 Q3 | 1.85 Billion EUR | -2.19% |
| 2013 Q2 | 1.91 Billion EUR | 0.86% |
| 2013 FY | 7.53 Billion EUR | 1.35% |
| 2013 Q4 | 1.83 Billion EUR | -2.62% |
| 2013 Q3 | 1.88 Billion EUR | -1.7% |
| 2013 Q1 | 1.9 Billion EUR | 31.83% |
| 2012 FY | 7.43 Billion EUR | -0.7% |
| 2012 Q1 | 1.89 Billion EUR | -1.09% |
| 2012 Q2 | 2.04 Billion EUR | 7.8% |
| 2012 Q4 | 1.44 Billion EUR | -29.8% |
| 2012 Q3 | 2.05 Billion EUR | 0.45% |
| 2011 Q2 | 1.79 Billion EUR | -6.71% |
| 2011 Q3 | 1.85 Billion EUR | 3.16% |
| 2011 Q4 | 1.91 Billion EUR | 3.53% |
| 2011 FY | 7.48 Billion EUR | 8.44% |
| 2011 Q1 | 1.92 Billion EUR | 7.86% |
| 2010 Q4 | 1.78 Billion EUR | -1.88% |
| 2010 FY | 6.9 Billion EUR | 20.77% |
| 2010 Q3 | 1.81 Billion EUR | 7.53% |
| 2010 Q1 | 1.61 Billion EUR | 7.78% |
| 2010 Q2 | 1.69 Billion EUR | 4.87% |
| 2009 Q1 | 1.4 Billion EUR | 0.0% |
| 2009 Q2 | 1.39 Billion EUR | -0.7% |
| 2009 FY | 5.71 Billion EUR | 1.16% |
| 2009 Q3 | 1.42 Billion EUR | 2.59% |
| 2009 Q4 | 1.49 Billion EUR | 4.75% |
| 2008 FY | 5.65 Billion EUR | 7.1% |
| 2007 FY | 5.27 Billion EUR | 37.25% |
| 2006 FY | 3.84 Billion EUR | 9.83% |
| 2005 FY | 3.5 Billion EUR | 13.29% |
| 2004 FY | 3.09 Billion EUR | -14.88% |
| 2003 FY | 3.63 Billion EUR | 0.7% |
| 2002 FY | 3.6 Billion EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| MPH Health Care AG | 180.33 Million EUR | -6370.886% |
| Apontis Pharma AG | -3.33 Million EUR | 349868.674% |
| Dermapharm Holding SE | 342.86 Million EUR | -3303.42% |
| Evotec SE | 175.05 Million EUR | -6566.057% |
| PharmaSGP Holding SE | 91.63 Million EUR | -12633.939% |
| SynBiotic SE | 1.5 Million EUR | -774518.997% |